PGP and cancer: This suggests that TCZ, itraconazole, and posaconazole can sensitize P-gp-overexpressing-resistant cancer cells through alternate mechanisms, such as removing or inhibiting factors that block the effect of VIC in drug-resistant cancer cells, with co-treatment affording a synergistic effect on cells.